Nu Eyne

Seoul, South Korea Founded: 2017 • Age: 9 yrs
Medical devices using electrical stimulation for health conditions are developed.
Request Access

About Nu Eyne

Nu Eyne is a company based in Seoul (South Korea) founded in 2017.. Nu Eyne operates in a competitive market with competitors including CorneaGen, Cellusion, EyeGate, CorNeat Vision and Avedro, among others.

  • Headquarter Seoul, South Korea
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name New Ain Co., Ltd.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $507.07 K (USD)
    590
    as on Dec 31, 2024
  • Net Profit
    $7.36 M (USD)
    221
    as on Dec 31, 2024
  • EBITDA
    $8.82 M (USD)
    338
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Nu Eyne
Headcount 1-10
Employee Profiles 7
Employee Profiles
People
Dohyoung Kim
Executive
People
Hwa Sun
Manager, Operations
People
Pyungkyu Kim
Director, Business Development
People
Léa Jégo
Marketing Internship

Unlock access to complete

Funding Insights of Nu Eyne

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Nu Eyne

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Nu Eyne

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nu Eyne Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Nu Eyne

Nu Eyne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CorneaGen, Cellusion, EyeGate, CorNeat Vision and Avedro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutic devices for corneal transplants are developed by CorneaGen.
domain founded_year HQ Location
iPS cell-based technology for corneal endothelium regeneration is developed.
domain founded_year HQ Location
Therapeutics and drug delivery systems for eye diseases are developed.
domain founded_year HQ Location
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
domain founded_year HQ Location
Corneal collagen cross-linking technology is developed for ophthalmic applications.
domain founded_year HQ Location
Ophthalmic devices for corneal edema treatment are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nu Eyne

Frequently Asked Questions about Nu Eyne

When was Nu Eyne founded?

Nu Eyne was founded in 2017.

Where is Nu Eyne located?

Nu Eyne is headquartered in Seoul, South Korea.

What is the annual revenue of Nu Eyne?

Annual revenue of Nu Eyne is $507.07K as on Dec 31, 2024.

What does Nu Eyne do?

Nu Eyne was founded in 2017 and is located in Seoul, South Korea, within the medical devices sector. Devices are developed for treating conditions such as corneal diseases, facial nerve palsy, migraines, ADHD, and overactive bladder. Electrical stimulation is applied in these devices to induce and maintain sleep, support nerve function recovery, and regulate abnormal nervous system activities.

Who are the top competitors of Nu Eyne?

Nu Eyne's top competitors include CorneaGen, EyeYon and Avedro.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available